These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29493011)

  • 1. Synthesis of
    Hesk D; Koharski D; McNamara P; Royster P; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2018 Jun; 61(7):533-539. PubMed ID: 29493011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).
    Hesk D; Borges S; Hendershot S; Koharski D; McNamara P; Ren S; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2016 May; 59(5):190-6. PubMed ID: 26991320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of
    Hesk D; Borges S; Dumpit R; Hendershot S; Koharski D; McNamara P; Ren S; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2017 Apr; 60(4):194-199. PubMed ID: 28129428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of (3) H-labeled, (14) C-labeled, and (2) H4 -labeled SCH 444877, phosphodiesterase type 5 inhibitors.
    Ren S; Hesk D; McNamara P; Koharski D; Hendershot S
    J Labelled Comp Radiopharm; 2013; 56(9-10):480-4. PubMed ID: 24285525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 3H, 13C,2H3,15N and 14C-labelled SCH 466036, a histamine 3 receptor antagonist.
    Hesk D; Borges S; Dumpit R; Hendershot S; Koharski D; Lavey C; McNamara P; Voronin K
    J Labelled Comp Radiopharm; 2015 Feb; 58(2):36-41. PubMed ID: 25689968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
    Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
    Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The syntheses of isotopically labelled CB-1 antagonists for the treatment of obesity.
    Tran SB; Maxwell BD; Burrell R; Bonacorsi SJ
    J Labelled Comp Radiopharm; 2016 Dec; 59(14):665-672. PubMed ID: 27624665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis,
    Artelsmair M; Miranda-Azpiazu P; Kingston L; Bergare J; Schou M; Varrone A; Elmore CS
    J Labelled Comp Radiopharm; 2019 May; 62(6):265-279. PubMed ID: 30937946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis of
    Vaidyanathan S; Reed A; Du J
    J Labelled Comp Radiopharm; 2021 Jul; 64(9):356-362. PubMed ID: 34050966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of [
    Queen AE; Hesk D; Lindsay DM; Kerr WJ; Rehder K; Fennell T; Mascarella W; Zhong D; Runyon S
    J Labelled Comp Radiopharm; 2020 Apr; 63(4):196-202. PubMed ID: 32017204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthesis of tritium, carbon-14 and stable isotope labelled selective estrogen receptor degraders.
    Bragg RA; Bushby N; Ericsson C; Kingston LP; Ji H; Elmore CS
    J Labelled Comp Radiopharm; 2016 Sep; 59(11):454-61. PubMed ID: 27558079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses of a radiolabelled CXCR2 antagonist AZD5069 and its major human metabolite.
    Hickey MJ; Allen PH; Caffrey M; Hansen P; Kingston LP; Wilkinson DJ
    J Labelled Comp Radiopharm; 2016 Sep; 59(11):432-8. PubMed ID: 27461061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel non-peptidic neuropeptide Y Y2 receptor antagonists.
    Jablonowski JA; Chai W; Li X; Rudolph DA; Murray WV; Youngman MA; Dax SL; Nepomuceno D; Bonaventure P; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1239-42. PubMed ID: 14980673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations.
    Halldin C; Farde L; Barnett A; Sedvall G
    Int J Rad Appl Instrum A; 1991; 42(5):451-5. PubMed ID: 1646191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis of one H-2 labeled and two H-3 labeled leukotriene C4 synthase inhibitors.
    Bergare J; Kingston L; Guly DJ; Dolan J; Lewis RJ; Elmore CS
    J Labelled Comp Radiopharm; 2020 Aug; 63(10):434-441. PubMed ID: 32441366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of [(3) H], [(13) C3 , (15) N], and [(14) C]SCH 900567: an inhibitor of TNF-α (tumor necrosis factor alpha) converting enzyme (TACE).
    Ren S; Hesk D; McNamara P; Koharski D; Borges S
    J Labelled Comp Radiopharm; 2014 Sep; 57(11):632-6. PubMed ID: 25251383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis of isotopologues of AZD7307: A selective β
    Kingston LP; Hickey MJ; Elmore CS
    J Labelled Comp Radiopharm; 2019 Sep; 62(11):707-712. PubMed ID: 31215663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design.
    Guba W; Neidhart W; Nettekoven M
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1599-603. PubMed ID: 15745805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay.
    Beauverger P; Rodriguez M; Nicolas JP; Audinot V; Lamamy V; Dromaint S; Nagel N; Macia C; Léopold O; Galizzi JP; Caignard DH; Aldana I; Monge A; Chomarat P; Boutin JA
    Cell Signal; 2005 Apr; 17(4):489-96. PubMed ID: 15601626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of radioiodinated N-2-(4-piperidyl)ethyl benzamides.
    Efange SM; Michelson RH; Knusel B; Hefti F; Boudreau RJ; Thomas JR; Tennison JR
    Nucl Med Biol; 1993 May; 20(4):527-38. PubMed ID: 8504292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.